(Q88978462)
Statements
Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial (English)
0 references
Huijie Bian
0 references
Zhao-Hui Zheng
0 references
Ding Wei
0 references
Zheng Zhang
0 references
Wen-Zhen Kang
0 references
Chun-Qiu Hao
0 references
Ke Dong
0 references
Wen Kang
0 references
Jie-Lai Xia
0 references
Jin-Lin Miao
0 references
Rong-Hua Xie
0 references
Bin Wang
0 references
Xiu-Xuan Sun
0 references
Xiang-Min Yang
0 references
Peng Lin
0 references
Jie-Jie Geng
0 references
Ke Wang
0 references
Hong-Yong Cui
0 references
Kui Zhang
0 references
Xiao-Chun Chen
0 references
Hao Tang
0 references
Hong Du
0 references
Na Yao
0 references
Shuang-Shuang Liu
0 references
Lin-Na Liu
0 references
Zhe Zhang
0 references
Zhao-Wei Gao
0 references
Gang Nan
0 references
Qing-Yi Wang
0 references
Jian-Qi Lian
0 references
Zhi-Nan Chen
0 references
Ping Zhu
0 references
24 March 2020
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference